A real-world economic analysis of the cost implications of switching from sevelamer hydrochloride to lanthanum carbonate in the bundled reimbursement scheme

May 1, 2013, 00:00
10.1016/j.jval.2013.03.941
https://www.valueinhealthjournal.com/article/S1098-3015(13)01012-7/fulltext
Title : A real-world economic analysis of the cost implications of switching from sevelamer hydrochloride to lanthanum carbonate in the bundled reimbursement scheme
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)01012-7&doi=10.1016/j.jval.2013.03.941
First page : A187
Section Title : Health Services
Open access? : No
Section Order : 495
Categories :
Tags :
Regions :
ViH Article Tags :